ACCC logo
Facebook  LinkedIn  Twitter  ACCC Youtube Channel  ACCCBuzz blog

Association of Community Cancer Centers

The leading education and advocacy organization for the multidisciplinary cancer team

ACCCBuzz Blog  Find a Cancer Program  Log in to MyNetwork

Home > Surveys > Off-Label Drug Use Survey

2008 Survey: Off-Label Drug Use by Practices

The Association of Community Cancer Centers (ACCC) and Covance Market Access Services, Inc., have released a final report on the "Impact of Payer Coverage and Reimbursement Policies on Off-Label Use of Anticancer Therapies." The Pharmaceutical Research and Manufacturers of America (PhRMA), and the Biotechnology Industry Organization (BIO) also helped develop the survey.

Nearly half of the respondents report that their practice's frequency of off-label use of anticancer therapies has decreased over the past five years. Coverage and reimbursement challenges were the overwhelming reason cited by oncology practices for their decreased use of anticancer therapies for off-label uses. Oncology practices that report an increase in off-label use attribute their increased utilization to the availability of more drugs that have been shown to be effective in uses that are not yet FDA-approved.

Among other highlighted findings:

Using ACCC's comprehensive member list, Covance sent survey invitations to nearly 3,500 office-based oncology practices. A total of 165 responses were received from physicians, practice managers, and administrators in geographically diverse areas and of mixed practice sizes.

View the complete survey results (Login Required).

Copyright © 2017 Association of Community Cancer Centers. All Rights Reserved.
1801 Research Boulevard, Suite 400, Rockville, MD 20850  |  Tel.: 301.984.9496  |  Fax: 301.770.1949